188 related articles for article (PubMed ID: 27412038)
1. Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.
Park JK; Yang JA; Ahn EY; Chang SH; Song YW; Curtis JR; Lee EB
BMC Cancer; 2016 Jul; 16():381. PubMed ID: 27412038
[TBL] [Abstract][Full Text] [Related]
2. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
[TBL] [Abstract][Full Text] [Related]
3. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
[TBL] [Abstract][Full Text] [Related]
4. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.
Hsu CY; Ko CH; Wang JL; Hsu TC; Lin CY
Arthritis Res Ther; 2019 Oct; 21(1):211. PubMed ID: 31604447
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study.
Hsu HC; Chang YS; Hou TY; Chen LF; Hu LF; Lin TM; Chiou CS; Tsai KL; Lin SH; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
Clin Rheumatol; 2021 Sep; 40(9):3755-3763. PubMed ID: 33646447
[TBL] [Abstract][Full Text] [Related]
6. Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: A nationwide, population-based cohort study.
Ng KH; Chen DY; Lin CH; Chao WC; Chen YM; Chen YH; Huang WN; Hsieh TY; Lai KL; Tang KT; Chen HH
Semin Arthritis Rheum; 2020 Oct; 50(5):840-845. PubMed ID: 32896697
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
8. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan.
Ohta A; Nagai M; Nishina M; Tomimitsu H; Kohsaka H
Mod Rheumatol; 2013 Jul; 23(4):759-64. PubMed ID: 22903259
[TBL] [Abstract][Full Text] [Related]
9. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cancer incidence among patients with rheumatic disease: a retrospective cohort study.
Chang SH; Park JK; Lee YJ; Yang JA; Lee EY; Song YW; Lee EB
Arthritis Res Ther; 2014 Aug; 16(4):428. PubMed ID: 25163486
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary pathology of the rheumatic diseases.
Leslie KO; Trahan S; Gruden J
Semin Respir Crit Care Med; 2007 Aug; 28(4):369-78. PubMed ID: 17764055
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
Lin CY; Ko CH; Hsu CY; Chen HA
Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and mortality of polymyositis and dermatomyositis patients.
Airio A; Kautiainen H; Hakala M
Clin Rheumatol; 2006 Mar; 25(2):234-9. PubMed ID: 16477398
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study.
Tsai SY; Lin CL; Wong YC; Yang TY; Kuo CF; Cheng JM; Wang JS; Kao CH
Medicine (Baltimore); 2015 Jul; 94(28):e1138. PubMed ID: 26181551
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
16. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF
Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620
[TBL] [Abstract][Full Text] [Related]
17. Detection of large macrophage colony forming cells in the peripheral blood of patients with rheumatoid arthritis.
Horie S; Nakada K; Masuyama J; Yoshio T; Minota S; Wakabayashi Y; Hirose S; Kano S
J Rheumatol; 1997 Aug; 24(8):1517-21. PubMed ID: 9263144
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus.
Kadoya A; Okada J; Iikuni Y; Kondo H
J Rheumatol; 1996 Jul; 23(7):1186-8. PubMed ID: 8823690
[TBL] [Abstract][Full Text] [Related]
20. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
